Transparency Market Research
Coccidiosis is a widespread disease caused by a single cell parasite that can be seen only with the help of a microscope. Every livestock species as well as wild animals can be infected by coccidiosis, which is particularly prevalent when animals or birds are grouped together in significant numbers. The disease results in lower egg production in chickens and is responsible for mortality in the flock. Commonly, three to four species of coccidian are responsible for the outbreak of the disease.
The severity of the disease depends on the number of oocyte ingested and on the species of coccidia. Anticoccidial drugs are those entities that combat the progression of coccidiosis in animals or birds. Anticoccidials are administered in the feed to prevent disease and minimize the economic loss often associated with sub-acute infections. Prophylactic use of anticoccidial drugs is preferred many a times as most of the damage occurs before clinical signs become apparent.
The anticoccidial drugs market can be segmented based on action, drug entity, and region. In terms of action, the anticoccidial drugs market can be classified into coccidiostatic and coccidiocidal. Based on drug entity, the anticoccidial drugs market can be categorized into ionophores and synthetic anticoccidials. The ionophores segment can be further divided into monovalent, monovalent glycoside, and divalent. Ionophores are the fermentation products of fungi species. They are extensively used as anticoccidial agents. Salinomycin, lasalocid, and monensin are the most commonly used ionophores. In terms of geography, the anticoccidial drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America accounts for a significant anticoccidial drugs market share in terms of revenue, due to a well-established infrastructure in immunological research, highly organized farming, increased demand for animal protein, high pet ownership, greater emphasis on prevention and wellness by veterinarians, and rise in spending on medicine. According to the USDA Economic Research Service, poultry is the fastest growing meat product in the organic products anticoccidial drugs market in the U.S.. The size of the poultry segment is around US$ 56 Mn. The segment expanded at an annual growth of 33% through 2008 (USDA, 2008).
The high consumption of meat is expected to propel the anticoccidial drugs market in North America. Europe is a prominent region of the anticoccidial drugs market, owing to a highly developed health care industry, high government funding for the development of veterinary medicines, increased awareness among people, and high consumption of meat. The Biotechnology and Biological Sciences Research Council (BBSRC) donated GBP 5.7 Mn for the development of poultry vaccines to the London School of Hygiene and Tropical Medicine in December 2015.
The anticoccidial drugs market in Asia Pacific is expanding at a robust pace due to high rate of development in veterinary medicines and increase in government initiatives. Nowadays, major pharmaceutical companies are outsourcing their drug development services to various countries such as China, Singapore, Malaysia, and India, which is eventually propelling the growth of the anticoccidial drugs market in this region. The global anticoccidial drugs market is witnessing considerable growth owing to a rise in disposable income of people in emerging countries. Disposable income is increasing in emerging countries such as India and China, which results in a change in lifestyle and high demand for animal protein foods such as meat, milk, etc.. Increase in disposable income is likely to boost demand for veterinary pharmacies. Middle East and Latin America are expected to be the prospective regions of the anticoccidial drugs market in the near future due to rapidly developing pharmaceutical and biotechnology industries.
Some of the major players operating in the anticoccidial drugs market are Bayer Animal Heath, Boehringer Ingelheim, Ceva Santé Animale, Elanco, Novartis Animal Health, Merck Animal Health, Merial, Virbac S.A., and Zoetis.
MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.
The report provides the following information:
The main aim of the report is to:
MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.